Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Wize Pharma Completes Phase IV Study of LO2A for Dry Eye Syndrome with Sjögren's Syndrome

americanpharmaceuticalreviewMay 12, 2020

Tag: Wize Pharma , LO2A , dry eye syndrome , Sjögren's Syndrome

PharmaSources Customer Service